Patent Yard Sign in
Canadian application, no grantCanada

Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design

CA 2421055 A1 · Owner: Taylor, Frederick R. · Inventors: Zheng, Zhongli; Karpusas, Michael; Taylor, Frederick R.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to compositions and crystals of CD154 (CD40L) in complex with an anti-CD154 antibody. In addition this invention relates to , the high resolution structure of a CD154/anti-CD154 antibody complex as obtained by X-ray crystallography. Specifically this structure provides , binding sites defined by the structure coordinates determined herein. This invention also relates to a computer (machine) comprising a machine-readable data storage medium comprising a data storage material encoded with machinereadable data comprising the structure coordinates provided by this invention. The computer has instructions to process said machine-readable data into a …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 31, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 31, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 31, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 31, 2001
GrantedNo grant recorded
Term endedAugust 31, 2021
Patent numberCA 2421055 A1
Classification (IPC)G01N33/48 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedAug 31, 2001Term endedAug 31, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.